Automated Lewis Score Estimation for Small Bowel Crohn Disease Using Capsule Endoscopy: Retrospective Cohort Study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Automated Assessment of Lewis Scores in Small-Bowel Crohn Disease With Capsule Endoscopy: A Retrospective Cohort Study

  • By

  • Yingying Meng

  • Min Gao

  • Jie Wu

  • Ying Huang

  • October 13, 2026

Share

Clinical Scorecard: Automated Assessment of Lewis Scores in Small-Bowel Crohn Disease With Capsule Endoscopy: A Retrospective Cohort Study

At a Glance

CategoryDetail
ConditionSmall-bowel Crohn disease and mucosal inflammatory activity assessed with the Lewis score
Key MechanismsEval-Model combines lesion detection and localization, edema and ulcer segmentation, stenosis classification, and LSTM-based temporal regression to estimate an examination-level Lewis score from sequential capsule endoscopy images.
Target PopulationPatients with small-bowel Crohn disease undergoing small-bowel capsule endoscopy; study cohort details are not provided in the supplied text.
Care SettingSmall-bowel capsule endoscopy interpretation and assessment of inflammatory activity in Crohn disease.

Key Highlights

  • Small-bowel capsule endoscopy visualizes Crohn disease lesions throughout the small intestine, but examinations may contain tens of thousands of frames.
  • The Lewis score quantifies small-bowel mucosal inflammatory activity using villous edema, ulceration, and stenosis.
  • Manual Lewis score calculation requires extensive image review and is vulnerable to interobserver variability.
  • Eval-Model integrates lesion identification and localization, edema and ulcer segmentation, stenosis categorization, and sequence-level temporal regression.
  • The supplied article excerpt describes the model and study rationale but does not provide cohort results or performance estimates.

Guideline-Based Recommendations

Diagnosis

  • The Lewis score is used to quantify small-bowel mucosal inflammatory change based on villous edema, ulceration, and stenosis.
  • Small-bowel capsule endoscopy enables visualization of Crohn disease lesions throughout the small intestine.

Management

    Monitoring & Follow-up

    • The source states that small-bowel mucosal activity affects treatment selection, monitoring strategies, and prognosis.

    Risks

    • Bile, bubbles, food residue, and incomplete mucosal visualization can impair capsule endoscopy image quality and may increase variability in lesion interpretation.
    • Manual Lewis score calculation is time-consuming and vulnerable to interobserver variability.

    Patient & Prescribing Data

    Patients with small-bowel Crohn disease undergoing capsule endoscopy; specific eligibility criteria and cohort characteristics are not included in the supplied excerpt.

    The article excerpt describes an automated assessment model, not a treatment or prescribing intervention. It notes that mucosal activity affects treatment selection but provides no treatment recommendations.

    Clinical Best Practices

    • Assess small-bowel inflammatory activity in the context of capsule endoscopy findings and the Lewis score components described in the source.
    • Recognize that image quality limitations, including bile, bubbles, food residue, and incomplete mucosal visualization, can affect lesion interpretation.
    • Treat Eval-Model as an automated estimation approach described in the study; the supplied excerpt does not establish its clinical performance or replace manual interpretation.

    Related Resources & Content

    Original Source(s)

    Related Content